Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model
Contributeurs/tricesSolly, F.; Fish, Richard![orcid](assets/images/orcid.png)
; Simard, B.; Bolle, N.; Kruithof, Egbert; Polack, B.; Pernod, Gilles
![orcid](assets/images/orcid.png)
Publié dansCancer gene therapy, vol. 15, no. 10, p. 685-692
Date de publication2008
Résumé
Mots-clés
- Angiostatins/metabolism
- Angiotensin-Converting Enzyme Inhibitors/pharmacology/therapeutic use
- Animals
- Antigens, CD31/analysis
- Blotting, Western
- Captopril/pharmacology/therapeutic use
- Cell Line, Tumor
- Combined Modality Therapy
- Gene Therapy/methods
- Genetic Vectors/genetics
- Glioma/drug therapy/pathology/therapy
- Immunohistochemistry
- Lentivirus/genetics
- Male
- Mice
- Mice, Nude
- Neovascularization, Pathologic/drug therapy/metabolism/therapy
- Rats
- Tissue Plasminogen Activator/genetics/metabolism/physiology
- Tumor Burden/drug effects
- Xenograft Model Antitumor Assays
Citation (format ISO)
SOLLY, F. et al. Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model. In: Cancer gene therapy, 2008, vol. 15, n° 10, p. 685–692. doi: 10.1038/cgt.2008.36
Identifiants
- PID : unige:2535
- DOI : 10.1038/cgt.2008.36
- PMID : 18535615
ISSN du journal0929-1903